INTRODUCTION {#sec1-1}
============

Absent pulmonary valve syndrome (APVS) is a rare malformation that can occur in 3-6% of patients with Tetralogy of Fallot (TOF).\[[@ref1]\] The condition is characterized by all the classic findings of TOF (pulmonary stenosis, overriding aorta, anterior malaligned ventricular septal defect \[VSD\], and right ventricular hypertrophy) along with rudimentary or absent pulmonary valve tissue. Absence of the pulmonary valve causes pulmonary regurgitation and aneurysmal dilatation of the main and branch pulmonary arteries (with right pulmonary artery more frequently dilated than left) that can compress the trachea and main stem bronchi.\[[@ref2]\] Vascular compression may even occur among the intrapulmonary bronchi due to abnormal pulmonary artery branching during fetal life predisposing patients to develop varying degrees of more distal obstructive airway disease.\[[@ref3][@ref4]\] The extent of the obstructive airway disease contributes to the patient\'s morbidity and mortality before and after surgery.

TOF-APVS patients can be clinically differentiated into two groups; those who present with respiratory symptoms prior to surgery and those who do not. The groups are equally divided and likely represent the severity of the disease process for that individual patient. For TOF-APVS patients who present prior to surgery their respiratory symptoms tend to occur in the first 3 months of life.\[[@ref5]\] In contrast, patients without respiratory symptoms follow a course similar to patients with classic TOF. Given the variability in the clinical degree of obstructive airway disease among children with TOF-APVS, objective quantification of the degree of airway obstruction before and after surgery may be helpful for their clinical management and prognosis. To date, there have been no published reports to quantify the degree of airway obstruction in patients with TOF-APVS. The purpose of this study is to present our experience with five patients with TOF-APVS and demonstrate the utility of performing pulmonary function tests (PFT) during the peri-operative period for these patients.

MATERIALS AND METHODS {#sec1-2}
=====================

This is a single-institution, retrospective study describing the clinical outcomes of five patients with TOF-APVS who had pulmonary function tests (PFT). We reviewed each patient\'s medical record to determine the hospital course including birth history, clinical presentation, surgical procedure, post-operative course, duration of mechanical ventilation, duration of intensive care unit (ICU) stay, and outcome. PFTs were performed as part of routine clinical care while these patients were intubated and mechanically ventilated. The patients were receiving ongoing sedation titrated to need based upon nursing and physician assessments. PFTs were performed in a standardized manner using the SensorMedics^®^ 2600 Infant PFT Cart (CareFusion, Yorba Linda, CA) and calibrated pneumotachometers (PNT). All five patients had PFTs measured post-operatively, and three had pre-operative values available for comparison.

Passive respiratory mechanics include measurement of tidal volume (V~T~), flow-volume waveforms, compliance of the respiratory system (C~RS~), and resistance of the respiratory system (R~RS~). The C~RS~ and R~RS~ were measured using a single-breath occlusion technique. The patient is observed during mechanical ventilation and an inline shutter/valve is activated close to end inspiration. This temporarily occludes the airflow provoking the Hering Breuer Inflation Reflex. Passive expiratory flow is measured through a PNT with a 0 to 35 L/min flow range (4500B series, Hans Rudolph, Shawnee, KS) and is analyzed for relaxation airway pressure, airflow, and volume, which are used to calculate C~RS~ and R~RS.~ The final C~RS~ and R~RS~ were calculated from the average of ten measured single breath occlusion events. Our measurement passive respiratory mechanics (C~RS~ and R~RS~) follow the standards set by the European Respiratory Society/American Thoracic Society (ERS/ATS) Task Force.\[[@ref6]\]

Raised volume-negative pressure forced deflations included measurement of forced vital capacity (FVC) and maximal expiratory flow 25% (MEF25). MEF25 is the forced flow when 25% of the forced vital capacity remains in the lungs. MEF25 (European convention) is therefore equivalent to Forced Expiratory Flow 75% (US convention). The ERS/ATS standard for raised volume forced expiration in infants primarily addresses techniques for non-intubated patients using rapid thoracic compression by means of a jacket surrounding the child with an inflatable bladder. Our measurements of FVC were performed in a different manner by means of a negative pressure forced deflation. This method has been previously described.\[[@ref7]\] The patients were manually ventilated with a self-inflating or flow-inflating anesthesia bag connected to wall oxygen and a pressure manometer. The endotracheal tube and anesthesia bag are connected to the side ports of a three-way directional sliding valve (8540 series, Hans Rudolph, Shawnee, KS). The third port is connected to a PNT inline to a 100 Liter reservoir maintained at a constant pressure of −40 cmH~2~O. During a measurement, the airway pressure is brought up to + 40 cmH~2~O for 3 seconds and the sliding valve is activated. The endotracheal tube is now connected through the PNT to the −40 cmH~2~O reservoir. The resulting exhalation is measured by a PNT with a 0 to 100 L/min flow range (4719 series, Hans Rudolph, Shawnee, KS). Exhalation was maintained until expiratory flow ceased or for 3 seconds at which time the slider valve returned to its original position and the manual ventilation resumed.

Results of PFTs obtained were compared to values for normal patients used by our pulmonary function testing laboratory. The normal values for FVC, MEF25, C~RS~, and R~RS~ reflect those for normal patients obtained from published studies.\[[@ref7][@ref8][@ref9][@ref10][@ref11][@ref12]\]

RESULTS {#sec1-3}
=======

Summary details of the patient demographics are in [Table 1](#T1){ref-type="table"}. All patients presented in the newborn period and cyanosis or respiratory failure was the indication for the echocardiogram that led to the diagnosis. Two patients were unable to leave the hospital prior to their surgical correction. Four patients required bronchoscopy for clinical purposes following surgery and showed some degree of bronchomalacia. Four of the five patients survived and were eventually discharged home or transferred to a community hospital after surgery. These four survivors needed total mechanical ventilation ranging from 8 to 68 days (post-operative duration of mechanical ventilation was 8 to 58 days) and their hospitalization duration ranged from 22 to 139 days. In addition to closure of the ventricular septal defects (VSD), surgical correction of all patients included use of a pulmonary homograft. For patient 1, the pulmonary homograft was placed during the second surgery with revision of a leaking VSD patch. Reduction pulmonary arterioplasty was performed in patients 2 and 3. Anterior translocation of the pulmonary arteries was performed in patients 2 and 4.

###### 

Patient characteristics
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Details of their PFTs are in [Table 2](#T2){ref-type="table"}. Three patients had pre-operative PFTs and all had elevation of their airways resistance (R~RS~). For two patients the PFTs results led to the use of increased positive end expiratory pressure (PEEP) for lung recruitment and to overcome intrinsic PEEP. Results of the PEEP titration curve are shown in [Table 3](#T3){ref-type="table"}. [Figure 1](#F1){ref-type="fig"} shows the results of a forced vital capacity maneuver for one patient with an idealized normal curve superimposed on it. [Figure 2](#F2){ref-type="fig"} shows a passive deflation flow-volume curves for patient 5. These curves were measured during the exhalation phase of a mechanical ventilator delivered tidal volume breath during a single breath occlusion measurement. Comparison of the flow-volume curves before and after surgical correction of TOF-APVS show increased airflow within the larger airways post-operatively but no changes in airflow within the small airways.

###### 

Pulmonary function testing (PFT) results

![](APC-8-108-g002)

###### 

Tidal volume measurements with increasing positive end expiratory pressure (PEEP)
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![Forced deflation flow-volume curve from pulmonary function testing for Tetralogy of Fallot (TOF)-absent pulmonary valve syndrome (APVS) patients. The flow-volume curve above obtained during a forced deflation maneuver shows marked concavity of the expiratory limb reflecting flow limitation within the medium and small airways. The dotted line approximates a normal forced deflation flow-volume curve and the arrows indicate the markedly decreased flows in TOF-APVS patients at 25% and 10% of forced vital capacity (FVC) compared with normal subjects](APC-8-108-g004){#F1}

![Passive deflation flow-volume curves for Patient \# 5 As part of the pulmonary function tests, passive deflation flowvolume curves were measured during the exhalation phase of a single occlusive breath. There is marked expiratory flow limitation demonstrated on both curves. Comparison of the flow-volume curves before and after surgical correction of Tetralogy of Fallot (TOF)- absent pulmonary valve syndrome (APVS) show increased airflow within the larger airways (within the arrows A and B) postoperatively but no changes in airflow within the small airways (represented beyond arrow B)](APC-8-108-g005){#F2}

DISCUSSION {#sec1-4}
==========

Despite the fact that obstructive respiratory disease can pose a relevant and serious cause for prolonged ventilator dependence in infants with TOF-APVS, there exists little to no information on the range of lung function abnormalities connected to this malformation and their changes after surgical correction. The patients in our study appear to have a severe form of TOF-APVS. Consistent with other studies\[[@ref3]\] all of our patients presented with respiratory symptoms within the first 3-months of life. These patients typically need early surgical correction to address the classic abnormalities of TOF and to relieve the airway compression by revision of the dilated pulmonary arteries.\[[@ref13][@ref14]\]

We found that all our ventilated infants with TOF-APVS had evidence of severe obstructive airway disease with increased R~RS~, reduced FVC, and reduced maximal expiratory flows. This represents the expected pathophysiologic changes caused by vascular airway compression of the large and small airways. R~RS~ reached values of comparable or even higher magnitude than we have previously measured in infants with respiratory failure due to severe RSV bronchiolitis (mean R~RS~0.37 \[0.06\] cmH~2~O/mL/sec).\[[@ref15]\]

The one patient who died in our cohort had the most severe degree of obstructive lung disease (Patient \# 5, pre-operative R~RS~0.66 cmH~2~O/mL/sec, post-operative R~RS~0.55 cmH~2~O/mL/sec) and was mechanically ventilated the longest (for 229 days until the patient\'s death). In our experience, fixed airway obstructions with such high R~RS~ values are usually incompatible with life. It has to be emphasized that passive mechanics data includes the physical characteristics of the endotracheal tube affecting C~RS~ to a minor and R~RS~ to a much greater extent. Normal R~RS~ in intubated infants have been previously reported by von Ungern-Sternberg *et al.*\[[@ref12]\] according to endotracheal tube (ETT) size and were 0.133 (SD 0.034cmH~2~O/mL/sec for ETT size of 3.0 mm and 0.066 (standard deviation \[SD\] 0.017) cmH~2~O/mL/sec for ETT of 3.5 mm. The equipment used in our measurements was identical to those of von Ungern-Sternberg *et al.*

We measured a decrease in R~RS~ after surgical correction which is however not reflected in the measurements of forced expiration. Forced deflation may fail to detect improvements in peripheral airway obstruction when bronchomalacia is present and airway collapse occurs during forced expiration. Surgical correction may relieve some of the airway obstruction caused by extrinsic compression but not improve the airway stability in patients with TOF-APVS. However, due to our small sample size, the clinical significance of this improvement in our patients with severe obstructive airway disease remains unclear.

For our patients with TOF-APVS, the information we obtained from PFTs were useful in the patient\'s post-operative ventilatory care. Adjustment of PEEP during pulmonary function testing showed improvement in the tidal volume and R~RS~ with PEEP greater than 10 cmH~2~O with clinical decrease in the work of breathing (WOB). This demonstrates the beneficial effect of PEEP stenting or stabilizing collapsible airways in patients with TOF-APVS. Interval measurements of PFTs were also helpful for the clinician especially during discussions with the family regarding the patient\'s clinical status and respiratory prognosis. As expected from pathophysiology, inhaled albuterol did not improve R~RS~ in the one patient where it was tested (data not shown). From our experience, we would recommend performing PFTs in TOF-APVS patients that require respiratory support both before and after surgery. One would hope to identify a reduction in R~RS~ with surgery approaching normal values. If there is no significant improvement that information would be valuable for prognosis. Should the patient have difficulty weaning from mechanical ventilation, we would suggest repeating PFTs during manipulation of PEEP.

The limitations of this study include the retrospective nature of the analysis involving a small cohort of severely ill patients with a rare variant of a cardiac disease. Due to the rarity of the absent pulmonary valve syndrome variant of TOF, it is difficult to make conclusions from the results of a small cohort of patients. Further, it is difficult to make conclusions for the less ill patients with TOF-APVS. To date, this is the only report quantifying the degree of obstructive lung disease using PFTs in TOF-APVS patients. Data from a larger cohort will be needed for a more robust analysis. Potentially, pulmonary function testing may play a role in adjusting the ventilator setting, and assessing the benefit of surgical correction and the evolution of airway obstruction during mechanical ventilation.
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